Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.

At ECR 2026, UII reaffirmed its AI development principles, which are anchored in clinical validation, regulatory rigor, and measurable outcomes. This approach transforms radiology knowledge into a ...

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services ConferenceCompany to Present and Host 1x1 Investor Meetings on ...

My daughter, the second her eyes open, without a care for anyone sleeping or what time it might be, right when the rosy ...

Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...

As Liz Cantor’s beloved mum Becky lay in a small cottage hospice on the Sunshine Coast, her daughter asked: “If you could ...

After learning that they carry a mutated version of the BRCA1 gene, their options were to undergo intensive monitoring every six months or to have preventive surgeries involving profound changes to th ...

What did these folks do to deserve to be God's favorites?

Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.

Scientists develop a high-performance photoacoustic endoscopy featuring a transparent ultrasound transducer. Recently, a research team consisting of Professor Chulhong Kim from the Department of ...

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...